Class Year



Alzheimer's Disease, dementia, Alzheimer's disease therapy


Alzheimer's disease (AD) is an incurable neurodegenerative disease and is the most common cause of dementia that affects elderly people (Izenberg, 2000). Today as citizens are living longer, AD is reaching epidemic proportions with no cure available (Tanzi and Bertram, 2005). In America, 4 million people are affected by this disease and it is estimated that the epidemic will jump 44 percent by the year of 2025 (Medline Plus, 2006). AD patients live debilitating lives of faulty memory, judgment, and reasoning (Tanzi and Bertram, 2005). However, a promising study published in Neuron by Simard et al. (2006) suggests a future therapeutic strategy. They employ stem cells that specifically target the amyloid deposits, the toxic culprit in this disease pathology.


Eukaryon is published by students at Lake Forest College, who are solely responsible for its content. The views expressed in Eukaryon do not necessarily reflect those of the College. Articles published within Eukaryon should not be cited in bibliographies. Material contained herein should be treated as personal communication and should be cited as such only with the consent of the author.